Hennion & Walsh Asset Management, Inc. Morpho Sys Ag Call Options Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.06 Billion
- Q3 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding MOR
# of Institutions
38Shares Held
1.82MCall Options Held
79.8KPut Options Held
688K-
Black Rock Inc. New York, NY1.02MShares$00.0% of portfolio
-
Segantii Capital Management LTD463KShares$01.04% of portfolio
-
Tekla Capital Management LLC177KShares$00.05% of portfolio
-
Engineers Gate Manager LP New York, NY13.4KShares$00.01% of portfolio
-
Quadrant Capital Group LLC Cincinnati, OH5.93KShares$00.01% of portfolio
About MorphoSys AG
- Ticker MOR
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 136,614,000
- Description
- MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...